The combination of Abrine and anti-PD-1 antibody obtained a better tumor inhibitory effect than the two used alone, indicating that there is a synergistic effect of Abrine with anti-PD-1 antibody on the treatment of HCC. Here, PDCD1 is linked to hepatocellular carcinoma.